Lonicerae flos polysaccharides improve nonalcoholic fatty liver disease by activating the adenosine 5′‐monophosphate‐activated protein kinase pathway and reshaping gut microbiota
- 29 July 2023
- journal article
- research article
- Published by Wiley in Journal of the Science of Food and Agriculture
- Vol. 103 (15) , 7721-7738
Abstract
BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is the most common cause of liver cirrhosis and cancer. Lonicerae flos polysaccharides (LPs) have been shown to be effective in treating metabolic diseases; however, the therapeutic effects and underlying molecular mechanisms of LPs in NAFLD remain unclear.PURPOSE: The objective of this study was to investigate the morphological characterization of Lonicerae flos polysaccharides (LPs) and the mechanism of LPs in relieving NAFLD.METHODS: The morphology of LPs was observed using atomic force microscopy (AFM), X‐ray diffraction (XRD), thermal weight (TG), and thermal weight derivative (DTG); NAFLD mice were treated with LPs at the same time as they were induced with a Western diet, and then the indexes related to glycolipid metabolism, fibrosis, inflammation, and autophagy in the serum and liver of the mice were detected.RESULTS: The atomic force microscope analysis results indicated that the LPs displayed sugar‐chain aggregates, exhibited an amorphous structure, and were relatively stable in thermal cracking at 150 °C. It was also found that LPs exerted therapeutic effects in NAFLD. The LPs prevented high‐fat and ‐cholesterol diet‐induced NAFLD progression by regulating glucose metabolism dysregulation, insulin resistance, lipid accumulation, inflammation, fibrosis, and autophagy. Adenosine 5′‐monophosphate (AMP)‐activated protein kinase (AMPK) inhibitor compound C abrogated LP‐induced hepatoprotection in mice with NAFLD. The LPs further treated NAFLD by reshaping the structure of the gut microbiota, in which Desulfovibrio bacteria plays a key roles.CONCLUSION: Lonicerae flos polysaccharides exert protective effects against NAFLD in mice by improving the structure of the intestinal flora and activating the AMPK signaling pathway. © 2023 Society of Chemical Industry.Keywords
Funding Information
- National Natural Science Foundation of China
This publication has 60 references indexed in Scilit:
- Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiotaNature Communications, 2015
- Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metforminNature Medicine, 2013
- Chlorogenic acid, a dietary polyphenol, protects acetaminophen-induced liver injury and its mechanismThe Journal of Nutritional Biochemistry, 2013
- Solution Properties and in Vitro Anti-Tumor Activities of Polysaccharides from Longan PulpMolecules, 2013
- Immune and inflammatory pathways in NASHHepatology International, 2013
- Omega-3 Fatty Acids, Hepatic Lipid Metabolism, and Nonalcoholic Fatty Liver DiseaseAnnual Review of Nutrition, 2013
- AMP-activated protein kinase—an energy sensor that regulates all aspects of cell functionGenes & Development, 2011
- The Role of Cytokines in Non-Alcoholic Fatty Liver DiseaseDigestive Diseases, 2010
- Autophagy regulates lipid metabolismNature, 2009
- Regulation of fatty acid synthesis and oxidation by the AMP-activated protein kinaseBiochemical Society Transactions, 2002